Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AM

Andreas Menrad — 26 Patents

SCSchering: 15 patents #182 of 2,442Top 8%
Novartis Ag: 6 patents #703 of 5,128Top 15%
PSPhilogen S.P.A.: 3 patents #14 of 55Top 30%
GEGenzyme: 3 patents #229 of 891Top 30%
BABayer Schering Pharma Ag: 2 patents #137 of 464Top 30%
MAMorphosys Ag: 1 patents #63 of 111Top 60%
ETEberhard Karls Universität Tübingen: 1 patents #33 of 95Top 35%
St Ives, GB: #9 of 419 inventorsTop 3%
Overall (All Time): #150,017 of 4,157,543Top 4%
26 Patents All Time
Andreas Menrad has been granted 26 US patents while listed as an inventor at Schering. The first was granted in 2002 and the most recent in November 2021. Andreas Menrad ranks #150,017 of 4,157,543 US inventors in our database (top 3.6%). Patent records list Andreas Menrad in St Ives, GB.

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11186638 Anti-αβTCR antibody Daniel Snell, Gina Lacorcia, Srinivas Shankara, Huawei Qiu, Clark Pan +1 more 2021-11-30
11142575 Methods for enhancing immunosuppressive therapy by multiple administration of αβTCR-binding polypeptide Gregor Blank, Rupert Handgretinger, Karin Schilbach, Gina Lacorcia, Daniel Snell 2021-10-12
10017573 Anti-αβTCR antibody Daniel Snell, Gina Lacorcia, Srinivas Shankara, Huawei Qiu, Clark Pan +1 more 2018-07-10
9289470 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart Dario Neri, Hans Dietrich Menssen, Christoph Schliemann 2016-03-22
8796426 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart Dario Neri, Hans Dietrich Menssen, Christoph Schliemann 2014-08-05
7851599 Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine Hans Dietrich Menssen, Karola Wagner 2010-12-14
7785591 Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies Josef Prassler, Armin Weidmann 2010-08-31
7615565 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Andreas Huth, Ludwig Zorn, Martin Kruger, Stuat Ince, Karl-Heinz Thierauch +2 more 2009-11-10
7517894 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Andreas Huth, Ludwig Zorn, Martin Krueger, Stuart Ince, Karl-Heinz Thierauch +2 more 2009-04-14
7479491 Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors Dieter Seidelmann, Martin Krueger, Eckhard Ottow, Andreas Huth, Karl-Heinz Thierauch +1 more 2009-01-20 $112,505,000
7459470 N-oxide anthranylamide derivatives and their use as medicaments Alexander Ernst, Andreas Huth, Martin Krueger, Karl-Heniz Thierauch, Martin Haberey 2008-12-02
7429592 Cyanoanthranilamide derivatives and the use thereof as medicaments Alexander Ernst, Andreas Huth, Martin Krueger, Karl-Heinz Thierauch, Martin Haberey 2008-09-30
7335775 Effector conjugates, process for their production and their pharmaceutical use Markus Berger, Gerhard Siemeister, Ulrich Klar, Jörg Willuda, Klaus Bosslet 2008-02-26 $21,145,000
7202260 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones Andreas Huth, Martin Krueger, Ludwig Zorn, Stuart Ince, Rolf Bohlmann +3 more 2007-04-10
7148357 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Andreas Huth, Ludwig Zorn, Martin Kruger, Stuat Ince, Karl-Heinz Thierauch +2 more 2006-12-12
7129254 Effector conjugates, process for their production and their pharmaceutical use Markus Berger, Gerhard Siemeister, Ulrich Klar, Jörg Willuda, Klaus Bosslet 2006-10-31 $758,000
7122547 Anthranilic acid amides and the use thereof as medicaments Andreas Huth, Dieter Seidelmann, Karl-Heinz Thierauch, Guido Bold, Paul W. Manley +8 more 2006-10-17
7081468 Ortho-substituted anthranilic acid amides and their use as medicaments Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch +2 more 2006-07-25 $6,981,000
7012081 Anthranyl amides and their use as medicaments Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch +2 more 2006-03-14 $6,466,000
7002022 N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul W. Manley, Jeanette Marjorie Wood +8 more 2006-02-21
6878720 VEGF receptor tyrosine kinase inhibitors Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul W. Manley, Jeanette Marjorie Wood +8 more 2005-04-12
6818661 Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors Dieter Seidelmann, Martin Kruger, Eckhard Ottow, Andreas Huth, Karl-Heinz Thierauch +1 more 2004-11-16 $19,212,000
6448277 VEGF receptor tyrosine kinase inhibitors Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul W. Manley, Jeanette Marjorie Wood +8 more 2002-09-10
6376480 Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents Gerald Kirsch, Andreas Steinmeyer, Gunter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt +2 more 2002-04-23 $407,000
6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments Gerald Kirsch, Andreas Steinmeyer, Gunter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt +2 more 2002-04-16 $378,000